Diquafosol (tradename Diquas) is a pharmaceutical drug for the treatment of
dry eye disease. It was approved for use in Japan in 2010. It is formulated as a 3% ophthalmic solution of the
tetrasodium salt
Salt is a mineral composed primarily of sodium chloride (NaCl), a chemical compound belonging to the larger class of salts; salt in the form of a natural crystalline mineral is known as rock salt or halite. Salt is present in vast quant ...
.
Its
mechanism of action
In pharmacology, the term mechanism of action (MOA) refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect. A mechanism of action usually includes mention of the specific molecular targ ...
involves
agonism
Agonism (from Greek ἀγών ''agon'', "struggle") is a political and social theory that emphasizes the potentially positive aspects of certain forms of conflict. It accepts a permanent place for such conflict in the political sphere, but seeks ...
of the
P2Y2 purinogenic receptor.
References
{{Purinergics
Ophthalmology drugs
Nucleotides